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Abstract
Photopolymerized biomimetic hydrogels with adaptable properties have been widely used for cell 
and tissue engineering applications. As a widely adopted gel crosslinking method, 
photopolymerization provides experimenters on-demand and spatial-temporal controls in gelation 
kinetics. Long wavelength ultraviolet (UV) light initiated photopolymerization is among the most 
popular methods in the fabrication of cell-laden hydrogels owing to its rapid and relatively mild 
gelation conditions. The use of UV light, however, still causes concerns regarding its potential 
negative impacts on cells. Alternatively, visible light based photopolymerization can be used to 
crosslink cell-laden hydrogels. The majority of visible light based gelation schemes involve 
photoinitiator, co-initiator, and co-monomer. This multi-component initiation system creates added 
challenges for optimizing hydrogel formulations. Here, we report a co-initiator/co-monomer-free 
visible light initiated thiol-norbornene photopolymerization scheme to prepare modular 
biomimetic hydrogels suitable for in situ cell encapsulation. Eosin-Y was used as the sole initiator 
to initiate modular gelation between synthetic macromers (e.g., thiolated poly(vinyl alcohol) or 
poly(ethylene glycol)) and functionalized extracellular matrices (ECM), including norbornene-
functionalized gelatin (GelNB) and/or thiolated hyaluronic acid (THA). These components are 
modularly crosslinked to afford bio-inert (i.e., purely synthetic), bioactive (i.e., using gelatin), and 
biomimetic (i.e., using gelatin and hyaluronic acid) hydrogels. The stiffness of the hydrogels can 
be easily tuned without affecting the contents of the bioactive components. Furthermore, the use of 
naturally-derived biomacromolecules (e.g., gelatin and HA) renders these hydrogels susceptible to 
enzyme-mediated degradation. In addition to demonstrating efficient and tunable visible light 
mediated gelation, we also utilized this biomimetic modular gelation system to formulate artificial 
tumor niche and to study the effects of cell density and gel modulus on the formation of pancreatic 
ductal adenocarcinoma (PDAC) spheroids.
Graphical abstract
*To whom correspondence should be sent: Chien-Chi Lin, PhD., Associate Professor, Department of Biomedical Engineering, Indiana 
University-Purdue University Indianapolis, Indianapolis, IN 46202, Phone: (317) 274-0760, lincc@iupui.edu. 
HHS Public Access
Author manuscript
Biomacromolecules. Author manuscript; available in PMC 2017 December 12.
Published in final edited form as:
Biomacromolecules. 2016 December 12; 17(12): 3872–3882. doi:10.1021/acs.biomac.6b00931.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
Keywords. Hydrogel; thiol-ene; tumor; modular crosslinking; gelatin; hyaluronic acid
1. Introduction
Biomimetic hydrogels with adaptable compositions and properties have tremendous 
potentials in both basic and applied research, including cell and molecular biology, drug 
delivery, tissue engineering, and regenerative medicine.1-3 From the viewpoint of material 
science and engineering, the compositions of biomimetic hydrogels must be well defined 
and highly controllable. From the perspective of basic biological science, the materials and 
protocols for hydrogel preparation must be readily available and adaptable for different 
laboratories with various research interests. Most importantly, the components and methods 
for hydrogel preparation should be highly cytocompatible. Photopolymerization is among 
the most reliable methods for hydrogel fabrication owing to its ease of preparation, highly 
controllable gelation kinetics, and predictable degradation (if appropriate degradable motifs 
are incorporated during macromer synthesis).4-7 Photopolymerized hydrogels have been 
widely used in biomedical applications, including biosensing and device coating, drug and 
protein delivery, in vitro cell culture and disease models, stem cell differentiation, and tissue 
regeneration.1, 2
In principle, any macromers with unsaturated vinyl groups can be crosslinked into hydrogels 
via photopolymerization. The following three groups of macromers are commonly adopted 
for fabricating biocompatible photopolymerized hydrogels: (1) Synthetic polymers, such as 
poly(ethylene glycol) (PEG) and poly(vinyl alcohol) (PVA); (2) Extracellular matrix (ECM)-
derived peptides/proteins, including collagen, gelatin, fibronectin, and recombinant proteins, 
etc.; and (3) Glycosaminoglycans (GAGs), including hyaluronic acid (HA), heparin sulfate, 
and chondroitin sulfate, etc. The popularity of synthetic polymers stems from their low cost 
of production, high lot-to-lot consistency in material properties, and high degree of control 
in chemical modification. On the other hand, the bioactive motifs (e.g., ligands for cell-
surface receptors, recognition sequences for protease cleavage) contained in ECM-derived 
proteins/peptides and GAGs are often utilized to mimic the biochemical milieu of natural 
tissues. These materials can be used alone or in combinations to form cell-laden hydrogels, 
Shih et al. Page 2
Biomacromolecules. Author manuscript; available in PMC 2017 December 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
as long as they are modified with photocrosslinkable motifs, such as acrylate, thiol, vinyl 
ether, and norbornene.4-6
We have previously reported the preparation of step-growth modular hydrogels using visible 
light-mediated thiol-norbornene photopolymerization with eosin-Y as the only 
photoinitiator.8, 9 The use of visible light negates the potential cellular and/or genetic 
damages imposed by ultraviolet (UV) light exposure. Furthermore, visible light initiated 
thiol-norbornene photochemistry eliminates the need for strong base co-initiator (e.g., 
triethanolamine, TEOA) and co-monomer (e.g., N-vinylpyrrolidone, NVP), two necessary 
components required in conventional visible light mediated photopolymerization.10-13 The 
elimination of co-initiator and co-monomer from the pre-polymer solution not only greatly 
simplifies material preparation, but also prevents potential toxicity of these small molecular 
weight molecules. Furthermore, the thiol-norbornene hydrogel crosslinking proceeds in a 
strictly modular and step-growth manner, which produces an idealized network with superior 
material properties at lower macromer contents.6, 9, 14 Compared with conventional visible 
light cured chain-growth hydrogels using the tri-initiator system (i.e., eosin-Y, TEOA, and 
NVP), we have shown that eosin-Y initiated thiol-norbornene gelation (Fig. 1A) is 
cytocompatible for three-dimensional (3D) culture of human mesenchymal stem cells 
(MSCs) and pancreatic MIN6 β-cells.9 We have also utilized this unique and simple gelation 
system to form multi-layer hydrogels,8 microgels,15 and islet surface conformal coating.16 
This gelation system was also used to prepare visible light cured thiol-norbornene hydrogels 
capable of undergoing UV-light-mediated photodegradation.17
While this visible light-mediated thiol-norbornene photochemistry has shown great 
potential, it has not been designed to impart biomimetic features (except for one example 
where pendant CRGDS peptide was immobilized in the otherwise inert PEG network).9 
Therefore, the primary focus of this contribution is on the development and characterization 
of step-growth, modular, and biomimetic hydrogels crosslinked from the macromers 
mentioned above, including synthetic macromers (e.g., thiolated PVA (TPVA), PEG-tetra-
thiol (PEG4SH), and PEG-di-norbornene (PEGdNB)), norbornene-functionalized gelatin 
(GelNB), and thiolated hyaluronic acid (THA). Visible light and eosin-Y mediated 
photochemistry was used to fabricate hydrogels that are either purely bio-inert (e.g., 
PEGdNB-TPVA or PEGdNB-PEG4SH gels), bio-active (e.g., TPVA-GelNB or PEG4SH-
GelNB), or biomimetic (e.g., GelNB-THA). When appropriately combined, these materials 
afford a diverse array of tailor-made hydrogels for 3D cell culture. In our previous work, we 
have explored UV light initiated thiol-norbornene PEG-peptide hydrogels for studying 
pancreatic ductal adenocarcinoma (PDAC) cell fate and drug responsiveness in 3D.18 Here, 
we use a PDAC cell line, COLO357, to demonstrate the utility of the visible light 
polymerized thiol-norbornene biomimetic hydrogels for in vitro study of PDAC cell fate.
2. Experimental Section
2.1 Materials
PEG4SH (MW: 10kDA) and four-arm PEG (MW: 20 kDa) were acquired from JenKem 
Technology USA. Thiolated hyaluronan (THA, 250 kDa), gelatin, and eosin-Y disodium salt 
were obtained from ESI Bio, Electron Microscopy Sciences, and MP Biomedical, 
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respectively. Collagenase (300 U/mg) and hyaluronidase (770 U/mg) were purchased from 
Worthington Biochemical. Linear PEG (MW: 10 kDa), 3-mercaptopropionic acid (MPA) 
and all other chemicals were purchased from ThermoFisher Scientific unless noted 
otherwise.
2.2 Macromer synthesis
The following macromers were synthesized in house: TPVA (6 kDa), PEGdNB (10 kDa), 
and GelNB (type B, 225 Bloom). GelNB synthesis was achieved through reacting gelatin 
with carbic anhydride as described previously.19, 20 Fluoraldehyde reagent was used to 
quantified the degree of norbornene functionalization on gelatin. Using unmodified gelatin 
with known concentrations as standards, the degree of functionalization was determined to 
be ∼2.22 mM norbornene per 1 wt% of GelNB. PEGNB was synthesized through reacting 
PEG-OH with 5-norbornene-2-carboxylic acid following an established protocol.6, 14 TPVA 
was synthesized following an established protocol with modified purification method.21 
Briefly, mixture of hydrochloric acid (5 ml, 12 N) and MPA (25 mL) was added slowly into 
PVA (5 g) pre-dissolved in 50 mL ddH2O at 60°C. After 24 hours of reaction, the product 
was transferred to a dialysis bag (MWCO: 3600 Da, Spectrum lab) and dialyzed for 3 days 
in slightly acidic ddH2O (pH 6.5). The product was recovered, lyophilized, and the degree of 
thiolation was quantified by Ellman's assay.
2.3 Hydrogel crosslinking and rheometry
Hydrogels were fabricated by reacting norbornene moieties of macromers with thiol 
containing crosslinkers via step-growth photopolymerization.6, 9 Precursor solutions 
comprised of 0.1 mM EY and desired concentrations of TPVA/PEGNB, TPVA/GelNB, or 
THA/GelNB were irradiated with visible light (400 – 700 nm, 5 minutes at 70k Lux) using a 
halogen cold light lamp (AmScope).8, 9 In situ gelation and rheological properties of the 
hydrogels were characterized with a digital rheometer (Bohlin CVO 100). In situ 
photorheometry was achieved by polymerizing hydrogel (100 μL) on a quartz plate in a light 
cure cell with a 25 mm parallel plate geometry. Visible light was directed to the bottom of 
the quartz plate through a flexible light guide and moduli were recorded in a time-sweep 
mode using 10 % strain, 1 Hz frequency, and a gap size of 90 μm. The time where storage or 
shear modulus (G′) exceeded loss modulus (G″) was recorded as the gel point. To obtain 
moduli of preformed gels with different formulations, 50 μL of pre-polymer solutions were 
polymerized between glass slides separated by 1mm-thick Teflon spacers. An 8 mm biopsy 
punch was used to obtain disc-shaped hydrogels for moduli measurements using a parallel 
plate under strain-sweep mode (0.1% to 5% strain) at 1 Hz frequency.
2.4 Characterization of hydrogel degradation
Visible light polymerized bio-inert TPVA/PEGNB hydrogels were incubated in pH 7.4 PBS 
and shear moduli of the hydrogels at different time points were used to determine their 
hydrolytic degradation. Data obtained from rheometry were fitted with pseudo-first order 
degradation kinetics as reported previously.14, 22 Bioactive (i.e., TPVA/GelNB) and 
biomimetic (i.e., GelNB/THA) hydrogels were used in proteolytic degradation studies. 
Briefly, hydrogels were formed and incubated in PBS for 2.5 hours at 37°C. Following 
measurement of the initial gel mass, hydrogels were transferred to wells containing 0.5 mL 
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of collagenase type I (10U/mL) or hyaluronidase (300U/mL) in PBS and incubated at 37°C. 
At predetermined time intervals, gels were removed from protease solution, blotted dry, and 
their mass was recorded. This process was repeated until no remnants of the gel could be 
seen. Results were presented as percent mass remaining to the initial gel mass before 
protease treatment.
2.5 Cell culture, encapsulation, and characterizations
PDAC cell line COLO-357 was cultured in high-glucose DMEM supplemented with L-
glutamine and sodium pyruvate, 10% fetal bovine serum (FBS), β-mercaptoethanol, and 
antibiotic-antimycotic. Cells were maintained in a standard cell culture incubator (37°C and 
5% CO2). For encapsulation in hydrogels, cells were suspended in pre-polymer solutions 
composed of eosin-Y, PEG4SH, GelNB, and/or THA at desired concentrations. Cell-laden 
hydrogels (20 μl/gel) were obtained through 5 minutes of visible light exposure (400-700 nm 
at 70kLux, equivalent to 10mW/cm2 at 550 nm). Following gel crosslinking, cell-laden 
hydrogels were maintained in cell culture incubator with media (500 μl per gel) refreshment 
every two days. To quantify cell metabolic activity, cell-laden hydrogels were incubated in 
500μL Alamarblue® reagent (AbD Serotec; 10 % in cell culture medium) for 2.5 hours. 
200μl of media was transferred to a 96-well plate for fluorescence quantification (excitation: 
560 nm and emission: 590 nm) using a microplate reader.
Live/dead staining was used to evaluate the viability and spheroid size of the encapsulated 
cells. Briefly, cell-laden hydrogels were stained with live/dead staining kit (Calcein AM 
stained live cells green and Ethidium homodimer-1 stained dead cells red) for an hour, 
washed with HBSS for 10 minutes, followed by confocal microscopy imaging (FV1000 
Laser Scanning Biological Microscope). Random fields in the hydrogels were selected for 
scanning and the gel thickness in any image was 100μm (step size of 10μm). The diameter 
of the spheroids on day 10 was determined using Nikon NIS Elements software. F-actin 
staining was achieved using Phalloidin. Briefly, cell-laden hydrogels were fixed with 4 % 
paraformaldehyde for 1 hour at room temperature on an orbital shaker. After cell fixation, 
hydrogels were washed twice with HBSS (10 minute/wash). Cells were then permeabilized 
with 0.5 % of TritonX-100 in HBSS for 45 minutes before washing twice with HBSS (10 
minutes/wash). Cell-laden gels were incubated in phalloidin solution (at 100 nM) overnight 
at 4°C. Before imaging, cell nuclei were counter-stained with DAPI for an hour at room 
temperature and washed three times with HBSS (10 minutes/wash). Hydrogels were imaged 
with a confocal microscope as described above.
2.6 RNA isolation and gene expression analysis
In preparation for RNA isolation, cell-laden gels and cells recovered from control 2D culture 
were rapidly frozen using liquid nitrogen and stored in -80°C until use. Collected samples 
were processed following NucleoSpin® RNA protocols (Clontech). The concentrations of 
pure RNA were determined using NanoDrop 2000 Spectrophotometer (Thermo Scientific). 
PrimeScript™ RT Reagent Kit (Clontech) was used to convert RNA into cDNA. 
Quantitative real time PCR (Applied Biosystems 7500 Fast Real-Time PCR machine) was 
performed using cDNA and SYBR Premix Ex Taq II kit (Clontech) with appropriate primers 
(F: forward, R: reverse): GAPDA-F: GAAGGTGAAGGTCGGAGTC; GAPDF-R: 
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GAAGATGGTGATGGGATTTC;23 CTGF-F: AGGAGTGGGTGTGTGACGA; CTGF-R: 
CCAGGCAGTTGGCTCTAATC;24 SHH-F: GGAAGCAGCCTCCCGATT; SHH-R: 
CGAGTCCAAGGCACATATCCA;25 MMP14-F: GCAGAAGTTTTACGGCTTGCA, 
MMP14-R: TCGAACATTGGCCTTGATCTC.26 2-ΔΔct method was used for data analysis 
where GAPDH was used as the housekeeping gene. Gene expression levels from hydrogel 
samples were further compared to the 2D samples collected on respective day of culture.
2.7 Statistical analysis
All experiments were conducted independently for three times with a minimum of three 
samples per conditions. Numerical data were reported as Mean ± SD and analyzed with two-
way ANOVA on GraphPad Prism 5 software (p < 0.05 signifies statistical significance).
3. Results
3.1 Modular crosslinking of visible light polymerized thiol-norbornene hydrogels
To obtain visible light-initiated step-polymerized hydrogels with modular properties (Fig. 
1A), we utilized a range of bio-inert (TPVA, PEGdNB, or PEG4SH) or bioactive (GelNB or 
THA) macromers with either thiol or norbornene moiety (Fig. 1B). We named the three 
classes of step-polymerized thiol-norbornene hydrogels as below: bio-inert (TPVA
+PEGdNB), bioactive (TPVA+GelNB), and biomimetic hydrogels (GelNB+THA). In situ 
photorheometry was used to evaluate gelation efficiency. For both bio-inert (Fig. 1C) and 
bioactive (Fig. 1D) hydrogels, the gel point (time when G′ surpasses G″) was around 25 
seconds. On the other hand, the gel point of biomimetic gelation system was significantly 
faster (∼5 seconds, Fig. 1E) than both bio-inert and bioactive systems. The gelation of all 
three groups of gels reached near completion after 5 minutes of visible light exposure.
3.2 Modularly tunable stiffness in visible light cured thiol-norbornene hydrogels
Fig. 2 shows the high tunability of the matrix stiffness in bio-inert, bioactive, and 
biomimetic thiol-norbornene hydrogels. Fig. 2A demonstrates two levels of control in bio-
inert hydrogel crosslinking: the degree of thiol substitution (DS) in TPVA (DS = 26 or 40) 
and the number of polymerizable moiety or functionality (f) per PEGNB molecule (i.e., f = 2 
for PEGdNB and f = 4 for PEG4NB). Regardless of PEGNB functionality, hydrogels were 
significantly stiffer using TPVA with high DS (i.e., 40). However, the effect of PEGNB 
functionality on gel crosslinking was more apparent when high DS TPVA was used. Next, 
we demonstrated the independent control of gel stiffness by varying the content of bio-inert 
TPVA without affecting the amount of bioactive macromer incorporated (Fig. 2B). At a 
fixed GelNB content (i.e., 7 wt%), we adjusted the concentration of TPVA to 0.7, 1, and 1.3 
wt% so that the stoichiometric ratio of thiol-to-norbornene (RSH/ene) was 0.5, 0.75, and 1, 
respectively. Not surprisingly, gel modulus increased at increasing RSH/ene, a characteristic 
trend for orthogonally crosslinked hydrogels.6 Finally, the tunability of gel stiffness in 
biomimetic hydrogels composed of GelNB and THA was explored (Fig. 2C). Here, we fixed 
the concentrations of GelNB and THA to 7wt% and 1.1wt% respectively, while adjusting the 
content of another bio-inert macromer PEG4SH so that RSH/ene was maintained at 0.5, 0.75, 
or 1. The results are in accordance with that shown in Fig. 2B where an increase in RSH/ene 
leads to increasing gel stiffness.
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3.3 Hydrolytic and enzymatic degradation of visible light cured thiol-norbornene 
biomimetic hydrogels
Next, we examined the degradation of these visible light cured thiol-norbornene hydrogels. 
In gel formulations containing macromers with ester bonds (e.g., TPVA, PEGdNB, or 
PEG4NB, Fig. 1B), hydrogels could be degraded via hydrolysis.14, 27 Fig. 3A shows that the 
shear modulus (G′) of TPVA/PEGNB hydrogels decreased as a function of time, indicative 
of network cleavage and decreases in gel crosslinking density. Furthermore, the degradation 
profiles followed pseudo-first order hydrolysis kinetics (Fig. 3A) as reported 
previously.14, 22, 28 In terms of enzymatic degradation, we prepared hydrogels using GelNB/
PEG4SH or GelNB/THA (Fig. 3B) and subjected the gels to hyaluronidase (150 U/mL), 
which degrades hyaluronic acid but not gelatin. As expected, the mass of hydrogels 
containing no HA (i.e., GelNB/PEG4SH group) was not affected by hyaluronidase. 
However, changes in gel mass were noticeable in hydrogels crosslinked by THA. In the first 
36 hours of hyaluronidase incubation, the mass of GelNB-THA hydrogels increased 
substantially, suggestive of increasing water uptake due to partial network cleavage. After 36 
hours of hyaluronidase treatment, the mass of HA-containing biomimetic hydrogel (i.e., 
GelNB/THA) started to decrease until the gels completely dissolved. In addition to 
hyaluronidase, we also explored collagenase-mediated proteolytic degradation of 
GelNB/THA hydrogels that were crosslinked with 0, 1, and 2 wt% PEG4SH. The addition 
of PEG4SH led to gels with the same amount of bioactive components but different stiffness 
(Fig. 3C. G′ = 1, 2, 5 kPa for soft, medium, and stiff hydrogels, respectively). While all 
three groups of hydrogels contained the same amount of gelatin (i.e., 7wt% GelNB), the 
degradation exhibited stiffness-dependent kinetics. Specifically, soft GelNB/THA hydrogels 
degraded much faster than the stiffer hydrogels. Furthermore, hydrogels crosslinked with 1 
or 2 wt% PEG4SH (i.e., medium and stiff hydrogel) gained significant weight during the 
initial phase of collagenase treatment (i.e., 24 and 48 hours for medium and stiff hydrogels).
3.4 Effect of cell density on the formation of tumor spheroids in biomimetic hydrogels
The cytocompatibility of visible light cured thiol-norbornene hydrogels was evaluated by in 
situ encapsulation of COLO-357 cells, a PDAC cell line that forms spheroids when cultured 
in 3D hydrogels.18 Cells were first encapsulated at different cell densities (0.5, 2, 5 ×106 
cells/mL) in biomimetic hydrogels composed of GelNB (7wt%) and THA (0.8wt%). The 
shear moduli of this gel formulation were close to 1kPa (data not shown). Live/Dead 
staining and confocal images (Fig. 4A, top panel) showed that almost all cells remained 
alive following encapsulation regardless of cell density. After 10-day in vitro culture, cells 
formed spheroids with sizes that were inversely proportional to the initial cell density (Fig. 
4A, bottom panel). F-actin staining images also showed the inverse relationship between 
spheroid sizes and cell density at the time of encapsulation (Fig. 4B). Image analysis results 
showed that cell spheroid sizes were considerably larger when they were encapsulated at 
lower cell densities (average dia. ∼57 μm, 44 μm, or 21 μm for cells encapsulated at 0.5, 2, 
or 5×106 cells/mL, respectively. Fig. 4C). Furthermore, cells encapsulated at lower cell 
density grew into spheroids with higher heterogeneity in sizes (Fig. 4C, Fig. S1). We also 
quantified metabolic activity of the encapsulated cells over time using Alamarblue® reagent, 
which measures the reducing activity within the cytosol of living cells. Interestingly, while 
live/dead images clearly showed that all cells remained alive throughout the 10-day culture, 
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the metabolic activity of the cells increased only in the first three days and dropped 
gradually from day-3 to day-10, eventually reached similar levels as that in day 1 (Fig. 4D). 
While cells encapsulated at 0.5×106 cells/mL did not show significantly higher fluorescence 
than the blank media control, these cells were obviously alive and proliferated into round 
spheres (Fig. 4A-4C). This was because the Alamarblue® reagent incubation time was fixed 
at 2.5 hours for all cell densities as longer incubation times would lead to overflow in 
reading for samples with higher cell density. We also extracted total DNA from cells 
encapsulated in these gels and the results (Fig. S2) showed that the total DNA contents 
increased both as a function of time and the encapsulating cell density.
3.5 Effect of gel stiffness on the formation of tumor spheroids in biomimetic hydrogels
The impact of matrix stiffness on the formation of tumor spheres was studied using 
biomimetic hydrogels with fixed gelatin and HA weight percent (7 wt% GelNB and 0.9 wt% 
THA, respectively) and varied PEG4SH contents (0, 1, 2 wt%). The modulation of PEG4SH 
content allowed us to control gel stiffness (G′ = 1, 2, and 5kPa for soft, medium, and stiff 
gels, respectively. Fig. 2C) without altering the concentrations of biomimetic motifs. Since 
cell density at the time of encapsulation appeared to affect the size of tumor spheroids, we 
decided to encapsulate the cells at 2×106 cells/mL. Fig. 5A and Fig. 6A showed the live/
dead staining and F-actin staining images, respectively. Although all cells formed spheroids 
regardless of gel modulus, cells encapsulated in softer gels showed higher metabolic activity 
(Fig. 5B). Spheroid size analysis showed that cells encapsulated in soft gels continued to 
grow into larger spheroids from day-5 to day-10, whereas the growing of cell spheroids in 
stiff gels appeared to slow down after day-5 (Fig. 6B, Fig. S3A & S3B). Furthermore, 
hydrogels with medium stiffness promoted the formation of spheroids with higher 
heterogeneity in sizes after 10 days of culture (Fig. S3B). The effect of gel stiffness on the 
total DNA contents from cells encapsulated in these gels were evaluated at all three time 
points (i.e., day 1, 5, and 10). The results (Fig. S4) showed that the total DNA contents 
increased as a function of time. However, the DNA contents were lower in cells 
encapsulated in the stiffer hydrogels than those in the gels with soft and medium stiffness.
3.6 Effect of gel stiffness on gene expression in tumor spheroids formed in biomimetic 
hydrogels
Fig. 7 shows mRNA expression of three genes relevant to the growth of tumor spheres. The 
expression of connective tissue growth factor (CTGF, Fig. 7A) and sonic hedgehog (SHH, 
Fig. 7B) were evaluated because of their roles in tumor/organ size control, as well as in 
maintaining stemness in cancer stem cells (CSC).25, 29-32 Moreover, the expression of matrix 
metalloproteinase 14 (MMP14, Fig. 7C) was examined because of its importance in matrix 
cleavage during the growth of tumor spheres.18 Data were normalized to an arbitrary value 
of 1 based on the levels of mRNA expression from cells cultured in soft hydrogels (G′ ∼1 
kPa) for the same duration (i.e., 1, 5, or 10 days). At respective day of culture, CTGF mRNA 
expression levels (Fig. 7A) were generally lower when the cells were cultured in medium (G
′ ∼ 3kPa) and stiff (G′ ∼ 5 kPa) gels than in softer gels. However, the influence of stiffness 
on CTGF mRNA expression seems to be less significant as the cells formed spheroids (i.e., 
longer culture time) as there were upward trends in CTGF expression in medium and stiff 
gels. By contrast, SHH expression was generally higher in cells grown for longer time and in 
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stiffer hydrogels (Fig. 7B). Finally, the expression levels of MMP14 were higher in cells 
encapsulated in stiffer gels than in softer gels (Fig. 7C).
4. Discussion
Thiol-norbornene PEG-based hydrogels can be rapidly crosslinked by UV light (e.g., λ = 
365 nm) irradiation.33 However, the use of UV light poses a concern regarding cancer cell 
fate, especially for mutation-prone PDAC cells. In this contribution, we report the use of 
visible light (λ = 400-700 nm) initiated thiol-norbornene biomimetic hydrogels for culturing 
COLO357 cells, a PDAC cell line that forms spheroids in 3D culture.18, 34 Conventionally, 
visible light mediated gelation involves the use of (meth)acrylated macromers (e.g., PEGDA 
or gelatin-methacrylate) coupled with a dual-initiator system (e.g., eosin-Y and TEOA), as 
well as a co-monomer (e.g., NVP).11 Although careful adjustments of the formulations 
produce chain-polymerized hydrogels with desired materials properties, some of these 
required components (e.g., strong base TEOA) may pose undesired side effects to the 
encapsulated.9 On the other hand, we have reported a visible light initiated thiol-norbornene 
gelation system using low concentration of eosin-Y (0.1 mM) as the single photoinitiator 
(Fig. 1A).9 In the prior work, however, we did not explore the effect of co-polymerized 
bioactive components on cell fate processes. The current contribution fills this technological 
gap by providing a visible light based step-polymerized gelation strategy with modular 
controls in matrix properties. Owing to the orthogonal crosslinking nature of thiol-
norbornene chemistry, at least two types of macromers must be employed: one with thiol 
and the other with norbornene moiety.33 Three classes of macromers, including synthetic 
macromers and derivatives of gelatin and HA, were used to render the resulting hydrogels 
that are bio-inert (e.g., TPVA+PEGdNB), bioactive (TPVA+GelNB), or biomimetic (GelNB
+THA). Most of these macromers are commercially available (e.g., PEGNB, PEGSH, and 
THA), while others are easily synthesized in aqueous solution with mild reaction conditions 
(e.g., GelNB). Although either TPVA or multi-arm PEGSH could be used, the former 
provides a more economical option and a tunable degree of thiolation per macromer that 
could lead to higher degree of gel crosslinking. The gelation of visible light-based step-
polymerized hydrogel system was understandably slower (gel point: ∼ 5 to 25 seconds, Fig. 
1C-1E) than its counterpart where UV-light was used (typical gel point: ∼ 1 to 2 seconds). 
However, the gel points reported in this work were comparable to or even faster than that in 
our previous study using visible light initiated thiol-norbornene gelation with inert 
macromers PEG4NB and DTT (gel point ∼ 20 seconds).9 The incorporation of THA 
induced rapid gelation (Fig. 1E. Gel point ∼ 5 seconds), presumably due to the exceptionally 
high functionality of THA (DS: ∼216 thiols/THA molecule, per Ellman's assay for thiol 
quantification).
The ability to control matrix stiffness is becoming a critical consideration when designing 
hydrogels for 3D cell culture.24, 35 The major benefit of modular crosslinking is that matrix 
stiffness can be independently controlled without altering the bioactivity of the gel matrix. 
Here, we show that the stiffness of hydrogels, whether bio-inert, bioactive, or biomimetic, 
could be readily tuned by controlling various parameters, including the degree of 
substitution, macromer functionality, or simply the content of bio-inert macromer (Fig. 2). In 
particular, these manipulations could be achieved without affecting the content of bioactive 
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motifs, which are required for supporting cell survival in 3D but could become a 
confounding factor when evaluating the effect of matrix stiffness on cell fate.
Predictable or controllable degradation is also critical when engineering matrices for 3D cell 
culture.36-41 This is because matrix degradation, either through hydrolysis or proteolysis, 
affects many aspects of cell fate processes, including proliferation, migration, and 
differentiation. Here, we show that the visible light initiated step-polymerized thiol-
norbornene hydrogels exhibit various degrees of degradability, depending on the macromer 
constituents (Fig. 3). Whereas macromers containing ester bonds are degraded through 
simple hydrolysis, both gelatin and hyaluronic acid are susceptible to enzyme-specific 
degradation. Interestingly, the degradation of GelNB-based hydrogels exhibited different 
modes of degradation, depending on the degree of gel crosslinking. While GelNB hydrogels 
with lower crosslinking could be readily eroded through enzyme-mediated chain cleavage, 
highly crosslinked GelNB hydrogels required more time to reach sufficient cleavage and gel 
mass loss. This degradation behavior is in concord with our previous report using UV-light 
crosslinked GelNB-PEG hydrogels.19 This phenomenon can potentially affect cells' ability 
to model their ECM, which may lead to changes in cell spreading and proliferation, as well 
as alterations in intracellular signaling.
COLO-357 pancreatic cancer cell line was used as a model to illustrate the importance of 
matrix properties, particularly stiffness, on the growth of tumor spheres. We chose a PDAC 
cell line because this cancer is associated with marked stroma formation and marked 
increases in stiffness. We found that the visible light based step-polymerized biomimetic 
hydrogels were highly cytocompatible for in situ cell encapsulation (Fig. 4). Encapsulated 
cells were able to proliferate and form spherical cell clusters. Interestingly, cells 
encapsulated at lower cell density appeared to grow into larger and more heterogeneous 
spheroids. It is likely that some paracrine effects led to growth inhibition when cells were 
encapsulated at higher cell density (e.g., 5×106 cells/mL). The relationship of initial cell 
density and tumor spheroid size was previously observed in breast cancer cells grown in 
inert PEG-based hydrogels.42, 43 The authors attributed the increased spheroid size at low 
cell density to enhanced expression of CSC markers for breast cancer cells, such as CD44, 
ABCG2, and EGFR. Similar phenomenon could contribute to the results observed in Fig. 4. 
In addition to initial cell density, we also found that softer gels encouraged the formation of 
larger PDAC cell spheroids (Fig. 6). This was likely due to the fact that hydrogels with lower 
crosslinking density were less dense and were easily deformed by the growing spheroids. On 
the other hand, stiff hydrogels were tightly crosslinked and imposed significant strain on the 
cells, which leads to decrease in spheroid sizes. During the growth of PDAC tumor 
spheroids, cellular metabolic activity peaked at day-3, but gradually decreased in the next 7 
days regardless of initial cell density. Similar reduction in cell metabolic activity was 
observed when cells were encapsulated at the same cell density but within gels of different 
moduli (Fig. 5). It is worth noting that Alamarblue® reagent only measures non-specific 
reduction in cell metabolic activity. Results shown in Fig. 4D and 5B suggest that the 
metabolism of COLO-357 cells was affected by the formation of multicellular spheroids. 
The results were also cell-type specific and could be affected by culture media supplements, 
immobilized biochemical motifs, cell-cell interactions, and biophysical properties of the 
matrix. The results from additional total DNA quantification (Fig. S2, S4) were largely in 
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agreement with the live/dead staining images (i.e., showing sign of cell proliferation) but not 
with the metabolic activity assays. The latter highlights the complicated nature of tumor cell 
metabolism. Although the current data support the notion that matrix properties could affect 
cancer cell fate processes, future studies are required to elucidate the influence of these 
matrix properties on tumor cell morphogenesis, including proliferation, invasion, and even 
drug responsiveness.
The effects of matrix stiffness on PDAC cells were also evaluated using real time PCR of 
selective genes deemed to be relevant to the growth of tumor spheroids. Note that we 
normalized the gene expression levels first to GAPDA internal control, then to the 
expression levels in cells grown in soft hydrogels (G′ ∼ 1kPa). This allowed us to gain 
insights regarding the differences of cell fate processes on the mRNA level between cells 
grown in hydrogels with different stiffness. CTGF is an effector gene downstream of the 
HIPPO pathway, which regulates tissue homeostasis, organ size, tumorigenesis, and even 
chemoresistance.30, 32 The upregulation of CTGF could be a result of inactivation of the 
HIPPO pathway, whose activation suppresses tumor progression and metastasis.31 Our 
results (Fig. 7A) suggest that while cells encapsulated in medium and stiff hydrogels initially 
had lower CTGF expression than that in cells encapsulated in the soft gels, higher matrix 
stiffness might suppress HIPPO pathway (and hence promote tumor progression) at later 
time as the cells gradually formed spheroids. In contrast to CTGF, the expression of SHH 
was found to be higher in stiff gel matrix. SHH signaling contributes critically to pancreatic 
desmoplasia and upregulation of SHH has been associated with increased tumor 
progression.44 A stiffer matrix also promotes expression of MMP-14, especially at later 
phase of cell growth (day-5 and day-10). We have previously shown that both SHH and 
MMP14 were upregulated in COLO-357 cells stimulated with transforming growth factor β 
(TGFβ) and epidermal growth factor (EGF).18 This study shows that, without altering the 
contents of bioactive components (i.e., gelatin and hyaluronic acid) or soluble factors (e.g., 
TGFβ and EGF), matrix stiffness alone is sufficient to upregulate SHH and MMP14 
expression. The results reported here show vast differences of gene expression between cells 
encapsulated in soft and stiff hydrogels. For example, there was an upward trend in SHH 
expression in cells encapsulated in stiffer hydrogels overtime compared to cells grown in 
softer environment. Although it is not the focus of the current study, these gene expression 
data suggest the need to design additional experiments for understanding the mechanisms by 
which matrix properties affect PDAC cell fate. It is also worth noting that the results could 
be cell-type dependent and future studies should contain other PDAC cells, including cell 
lines and primary tumor cells. Nonetheless, the work presented in this contribution 
demonstrates the high tunability of visible light initiated thiol-norbornene biomimetic 
hydrogels and their potential in cancer cell research.
5. Conclusion
In conclusion, the current study explores the use of visible light polymerized thiol-
norbornene biomimetic hydrogels for PDAC cell research. The use of visible light negates 
potential concerns of UV light induced cellular damage while allowing facile fabrication of 
biomimetic cell-laden hydrogels using thiol- and norbornene-functionalized macromers. In 
particular, the gelation of biomimetic hydrogels composed of GelNB and THA was highly 
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efficient and cytocompatible for in situ encapsulation of PDAC cells. We determined that 
cell density and matrix stiffness are two critical parameters affecting the formation of tumor 
spheroids. Specifically, there exists an inverse relationship between cell density at the 
encapsulation and the size of tumor spheroids formed. Furthermore, stiffer matrix 
upregulated the expression of SHH and MMP-14, suggesting the important influence of 
matrix stiffness on tumor cell fate. Further work will focus on exploiting this modular and 
adaptable visible light initiated gelation system for studying cancer cell growth, dormancy, 
and invasion in 3D.
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Figure 1. Visible light initiated thiol-norbornene reaction for forming orthogonally crosslinked 
biomimetic hydrogels
(A) Schematic of thiol-norbornene reaction under visible light exposure and with eosin-Y as 
the only initiator. (B) Chemical structures of macromers used, including thiolated PVA 
(TPVA, 6kDa), PEG-di-norbornene (PEGdNB, 10kDa), PEG-tetra-thiol (PEG4SH, 10kDa), 
gelatin-norbornene (GelNB), and thiolated HA (THA, 250kDa). (C-E) Evolution of storage 
(G′) and loss (G′) modulus of visible light initiated bio-inert (C), bioactive (D), and 
biomimetic (E) thiol-norbornene gelation.
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Figure 2. Modularly tunable stiffness in visible light cured thiol-norbornene hydrogels
(A) Effect of TPVA degree of substitution (DS) and PEG functionality (PEGdNB or 
PEG4NB) on shear modulus of bio-inert thiol-norbornene hydrogel. (B) Effect of thiol/ene 
molar ratio (R[thiol]/[ene]) on shear modulus of bioactive thiol-norbornene hydrogels 
composed of GelNB (fixed at 7wt%) and TPVADS40 (at 0.7, 1, or 1.3 wt% for R[thiol]/[ene]= 
0.5, 0.75, and 1, respectively). (C) Effect of PEG4SH supplement on shear modulus of 
biomimetic thiol-norbornene hydrogels composed of GelNB (fixed at 7wt%) and THA 
(fixed at 1.1wt%). PEG4SH = 0, 1.2, 2.4 wt%, corresponding to R[thiol]/[ene]= 0.5, 0.75, and 
1.
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Figure 3. Degradation of visible light polymerized thiol-norbornene hydrogels
(A) Hydrolysis of bio-inert hydrogels composed of 0.5 wt% of TPVA and 3.6 wt% of 
PEGdNB or PEG4NB. Time dependent moduli were fitted to pseudo-first order hydrolytic 
degradation kinetics. (B) Hyaluronidase-mediated proteolytic degradation (at 37°C) of 
bioactive GelNB/PEG4SH and biomimetic GelNB/THA hydrogels (7wt% GelNB, 2wt% 
PEG4SH or 0.9wt% THA). (C) Collagenase-mediated proteolytic degradation (at 37°C) of 
biomimetic hydrogels with different stiffness (Collagenase: 100U/mL. Soft gel: ∼1 kPa, 
Medium: ∼2 kPa, Stiff gel: ∼ 5 kPa).
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Figure 4. Effect of cell density on the formation of pancreatic cancer cell spheroids
(A) Representative confocal z-stack images of live/dead stained COLO357 cells. (B) Images 
of F-actin/DAPI staining on day 10. (C) Cumulative distribution of cell spheroid diameter. 
(D) Cell viability as assessed by Alamarblue® reagent. All gel formulations contained 7 wt
% GelNB, 0.9 wt% THA.
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Figure 5. Effect of gel stiffness on the formation of pancreatic cancer cell spheroids
(A) Representative confocal z-stack images of live/dead stained COLO357 cells. (B) Cell 
metabolic activity as assessed by Alamarblue® reagent. All gel formulations contained 7 wt
% GelNB, 0.9 wt% THA, as well as 0, 1 or 2 wt% of PEG4SH (i.e., soft, medium and stiff 
hydrogel).
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Figure 6. Effect of gel stiffness on the sizes of pancreatic cancer cell spheroids
(A) Representative confocal z-stack images of COLO-357 cells stained with F-actin/DAPI. 
(B) Cumulative distribution of cell spheroid diameter. Gel formulations were identical to that 
used in Figure 5.
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Figure 7. Effect of gel stiffness on mRNA expression in encapsulated cells
(A) CTGF, (B) SHH, and (C) MMP14. Housekeeping gene: GAPDH. 1-fold: gene 
expression levels in cells encapsulated in soft (G′ ∼ 1kPa) gels at respective day of culture 
(i.e., day-1, 5, or 10). Gel formulations were identical to that used in Figure 5. Asterisks: 
**p<0.01, ***p<0.001.
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